Papers

1

Total Citations

6

H-Index

1

About

Albert Rauch has made significant contributions to the field of automated pharmacological assay development, with a particular focus on enhancing the efficiency and precision of drug discovery workflows. His most notable work, "Development of a Platform to Enable Fully Automated Cross-Titration Experiments" (2016), addresses a critical bottleneck in the hit-to-lead optimization process: the need for rapid, multi-concentration compound testing to determine potency and maximal effect. Rauch’s platform introduces a fully automated system for conducting cross-titration experiments, which are essential for characterizing compound interactions and performing agonist shift assays. This innovation streamlines the triage of high-throughput screening hits and accelerates lead optimization by reducing manual intervention and variability. While his citation count (6) reflects a specialized niche, the impact of his work lies in its practical utility for researchers seeking robust, high-throughput solutions for complex pharmacological profiling. Rauch’s contributions are particularly valuable for laboratories transitioning from manual to automated experimental paradigms, offering a reproducible framework that enhances data quality and throughput in early-stage drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Development of a Platform to Enable Fully Automated Cross-Titration Experiments
6 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago